Article
Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance.
International journal of clinical pharmacology and therapeutics - 1 Jul 2015
Kousar Shazia, Wafai Zahoor A, Wani Mushtaq A, Jan Tariq R, Andrabi Khurshid I
Abstract excerpt
AIMS AND OBJECTIVES: Variations in drug metabolizing genes are known to have a clinical impact on AED therapy. We genotyped normal and epileptic patient cohorts of monoethnic population of Kashmir valley for CYP2C9 gene and allelic polymorphism and investigated the effect of CYP2C9*2 and *3 polymorphism on the Pharmacokinetic and therapeutic and/or adverse pharmacodynamic responses to Phenytoin in the idiopathic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.